A recent research has found that people who develop a fever after their second COVID-19 vaccine dose generate greater antibody levels than those that don't. The study has been conducted by two hospitals in southwestern Japan city of Fukuoka, namely Kyushu University Hospital and Fukuoka City Hospital.

The report, published in Mainichi newspaper of Japan, stated that antibodies tend to follow the same pattern for people getting their third 'booster' vaccine dose.

"The higher the fever, the more effective vaccination is," the report said.

The hospitals conducted the research in May-June 2021 under which researchers measured the antibody levels of 335 nurses and clerical staff working at Fukuoka City Hospital after the participants received their second dose of Pfizer COVID-19 vaccine.

According to the study, higher level of antibodies were seen in people who developed a fever after the second dose of the vaccine.

Furthermore, people with higher fever level developed more antibodies. The report stated that individuals with a fever of 38 degrees Celsius or higher had (on average) 1.8 times the antibodies than those whose fever remained below 37 C.

Some of the other effects of the vaccine including headache and joint pain were unrelated to the antibody levels after the immunisation.

A number of studies have also underlined that using antipyretic analgesics to treat side effects such as fevers, arm swellings and headaches did not impact the level of antibodies. In spite of taking antipyretic analgesics, sufficient immunity was acquired by people who received the vaccination.

SOURCE: Khaleej Times

LINK: https://www.khaleejtimes.com/coronavirus/covid-19-higher-fever-from-vaccine-means-more-antibodies-research-finds